OPUS GENETICS INC (IRD:NASDAQ)
$4.12 -0.24 (-5.5046%)
Analysed OPUS GENETICS INC (IRD:NASDAQ) News Sources
Here is Why Opus Genetics (IRD) is One of the Best Performing NASDAQ Stocks
05-05-2026
yahoo.com
Opus Genetics Completes Enrollment in Cohort 1 of Phase 1/2 OPGx-BEST1 Gene Therapy Study
07-05-2026
yahoo.com
Opus Genetics Presents Clinical and Preclinical Data at ARVO 2026 Demonstrating Continued Pipeline Advancement in Inherited Retinal Diseases
07-05-2026
yahoo.com
Certara, Inc. (CERT) Q1 Earnings Miss Estimates
11-05-2026
yahoo.com
Opus Genetics Announces Financial Results for First Quarter 2026 and Provides Corporate Update
12-05-2026
yahoo.com
Opus Genetics, Inc. (IRD) Reports Q1 Loss, Misses Revenue Estimates
12-05-2026
yahoo.com
Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference
13-05-2026
yahoo.com
Opus Genetics Touts Retinal Gene Therapy Pipeline, September BEST1 Data Catalyst
26-05-2026
marketbeat.com
Opus Genetics to Present at the 2026 Jefferies Global Healthcare Conference
27-05-2026
yahoo.com
Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
28-05-2026
yahoo.com
What is the current price of OPUS GENETICS INC (IRD:NASDAQ)?
The current price of OPUS GENETICS INC (IRD:NASDAQ) is $4.12.
OPUS GENETICS INC (IRD:NASDAQ) absolute price change since previous trading day?
The absolute price change of OPUS GENETICS INC (IRD:NASDAQ) since the previous trading day is $-0.24.
OPUS GENETICS INC (IRD:NASDAQ) percentage price change since previous trading day?
The percentage price change of OPUS GENETICS INC (IRD:NASDAQ) since the previous trading day is -5.5046%.
What is the most recent average sentiment score for OPUS GENETICS INC (IRD:NASDAQ)?
The most recent average sentiment score for OPUS GENETICS INC (IRD:NASDAQ) is 64 out of 100.
What is the most recent average sentiment for OPUS GENETICS INC (IRD:NASDAQ)?
The most recent sentiment for OPUS GENETICS INC (IRD:NASDAQ) is .
SEC-8K** Filing Available For OPUS GENETICS INC (IRD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.